Is Personalized Dietary Therapy Effective for Individuals With Irritable Bowel Syndrome?

被引:1
|
作者
Zarini, Gustavo G. [1 ]
McLean, Michael A. [1 ]
Delgado, Savina I. [1 ]
机构
[1] Oxford Biomed Technol Inc, 3555 Fiscal Ct,Suite 9, Riviera Beach, FL 33404 USA
关键词
Personalized diet; irritable bowel syndrome; lifestyle eating and performance program; leukocyte activation assay; quality of life; QUALITY-OF-LIFE; FOOD INTOLERANCE; GASTROINTESTINAL SYMPTOMS; MANAGEMENT; IBS; HYPERSENSITIVITY; PREVALENCE; IMPACT; COMMON;
D O I
10.1177/15598276221112309
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Adverse reactions to foods and food additives have a critical role in clinical manifestations of irritable bowel syndrome (IBS). Personalized dietary modifications conducted under the supervision of a qualified health practitioner could considerably impact the clinical care and course of the condition. Objective: To investigate the clinical effectiveness of the Lifestyle Eating and Performance (LEAP) program based on the Leukocyte Activation Assay-MRT (LAA-MRT (R)) results in improving IBS symptoms and quality of life. Methods: The retrospective study included de-identified client records (n = 146) from private group practices seen by registered dietitians. The eligibility criteria were adults aged > 18 years old with an established diagnosis of IBS. Results: Participants were 46.7 +/- 12.6 years old and had a BMI of 26.7 +/- 6.1 kg/m(2); the majority were female (87.0%) and followed-up by a registered dietitian for 10.1 +/- 6.4 weeks. There was a significant reduction post-dietary intervention in overall Global Gastrointestinal Symptom Survey Scores (P < 0.001) and improvement in quality of life (P < 0.001). Conclusion: This study generates real-world evidence of an alternative treatment option for IBS using a personalized dietary approach. A more precise understanding of the effect of food intake reactions is vital for clinical improvements and enhancing health outcomes in IBS.
引用
收藏
页码:317 / 325
页数:9
相关论文
共 50 条
  • [21] A dietary survey of patients with irritable bowel syndrome
    Hayes, P.
    Corish, C.
    O'Mahony, E.
    Quigley, E. M. M.
    JOURNAL OF HUMAN NUTRITION AND DIETETICS, 2014, 27 : 36 - 47
  • [22] Dietary therapy for irritable bowel syndrome High expectations for low FODMAP diets
    Lebwohl, Benjamin
    Green, Peter H. R.
    Seidenberg, Ivan
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [23] Therapy for irritable bowel syndrome - Reply
    Mertz, H
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12): : 1263 - 1263
  • [24] Diet therapy for irritable bowel syndrome
    Bakulin, I. G.
    Avalueva, E. B.
    Oreshko, L. S.
    Sitkin, S., I
    Shevyakov, M. A.
    Serkova, M. U.
    Semenova, E. A.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (08) : 118 - 127
  • [25] NUTRITIONAL THERAPY OF IRRITABLE BOWEL SYNDROME
    FRIEDMAN, G
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1989, 18 (03) : 513 - 524
  • [26] Pain therapy in irritable bowel syndrome
    de Greck, M.
    Layer, P.
    Andresen, V.
    SCHMERZ, 2014, 28 (03): : 289 - 293
  • [27] Yoga as a Therapy for Irritable Bowel Syndrome
    D'Silva, Adrijana
    MacQueen, Glenda
    Nasser, Yasmin
    Taylor, Lorian M.
    Vallance, Jeff K.
    Raman, Maitreyi
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (09) : 2503 - 2514
  • [28] Bacterial therapy for irritable bowel syndrome
    Talley, Nicholas J.
    Irani, Mudar
    Keely, Simon
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (07): : 627 - 629
  • [29] Diagnosis and therapy of irritable bowel syndrome
    De Giorgio, R
    Barbara, G
    Stanghellini, V
    Cremon, C
    Salvioli, B
    De Ponti, F
    Corinaldesi, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 : 10 - 22
  • [30] Drug therapy: Irritable bowel syndrome
    Mertz, HR
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22): : 2136 - 2146